PRESERVED EJECTION FRACTION
Clinical trials for PRESERVED EJECTION FRACTION explained in plain language.
Never miss a new study
Get alerted when new PRESERVED EJECTION FRACTION trials appear
Sign up with your email to follow new studies for PRESERVED EJECTION FRACTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Real-World jardiance study targets heart failure in china
Knowledge-focused Not yet recruitingThis study will observe about 3,000 Chinese adults with a type of heart failure called HFpEF who are starting the drug Jardiance. Researchers want to see how effective and safe the drug is in everyday medical practice, not in a controlled lab setting. The study will track heart-r…
Matched conditions: PRESERVED EJECTION FRACTION
Sponsor: Boehringer Ingelheim • Aim: Knowledge-focused
Last updated May 26, 2026 11:23 UTC
-
New study to peek inside body to see how tirzepatide works on joints and heart
Knowledge-focused Not yet recruitingThis study observes 30 adults in Mexico who are already taking tirzepatide for conditions like diabetes or obesity. Researchers will use MRI scans, heart CT scans, and body composition tests to see how the drug affects knee cartilage, heart fat, and overall body health over one y…
Matched conditions: PRESERVED EJECTION FRACTION
Sponsor: JULIO GRANADOS MONTIEL • Aim: Knowledge-focused
Last updated May 18, 2026 12:07 UTC